Showing results (431-440 of 516) with videos related to
Sort By:
Pageof 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trialBirgitta Lannering, Stefan Rutkowski, Francois Doz, et al.Nature Protocols|July 28, 2026
Core2Edge: a human glioblastoma organoid-brain slice model capturing infiltration and transcriptional heterogeneity from core to single-cell dispersionAhmad Melhem, Barbara E F Pregler, Juan Eduardo Rodriguez-Gatica, et al.Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2019
Germline GPR161 Mutations Predispose to Pediatric MedulloblastomaMatthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.Neuro-Oncology|December 25, 2016
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start dataMartin Mynarek, Barry Pizer, Christelle Dufour, et al.Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.International Journal of Molecular Sciences|November 14, 2023
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic PathwaysSimona Serioli, Ludovico Agostini, Alberto Pietrantoni, et al.Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.International Journal of Cancer|March 12, 2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingGuido Reifenberger, Ruthild G Weber, Vera Riehmer, et al.Pageof 52